Minot Wealth Management LLC Regeneron Pharmaceuticals, Inc. Transaction History

Minot Wealth Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$548.35 - $738.84 $223,726 - $301,446	-408 Closed	0 $0
Q1 2022 Apr 14, 2022	BUY	$595.12 - $698.43 $8,926 - $10,476	15 Added 3.82%	408 $285,000
Q4 2021 Jan 20, 2022	SELL	$543.48 - $670.97 $108,696 - $134,194	-200 Reduced 33.73%	393 $248,000
Q3 2021 Oct 25, 2021	BUY	$574.03 - $680.96 $340,399 - $403,809	593 New	593 $359,000
Q2 2021 Jul 19, 2021	SELL	$472.8 - $558.54 $737,568 - $871,322	-1,560 Closed	0 $0
Q1 2021 Apr 29, 2021	BUY	$446.73 - $548.2 $696,898 - $855,192	1,560 New	1,560 $738,000
Q4 2020 Jan 28, 2021	SELL	$478.3 - $607.98 $1.46 Million - $1.85 Million	-3,050 Closed	0 $0
Q3 2020 Oct 13, 2020	BUY	$544.75 - $658.21 $393,854 - $475,885	723 Added 31.07%	3,050 $1.71 Million
Q2 2020 Jul 14, 2020	BUY	$493.32 - $643.92 $1.15 Million - $1.5 Million	2,327 New	2,327 $1.45 Million

1,535

83.8M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Minot Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Minot Wealth Management LLC with notifications on news.